Alternatives To Knee Replacement Surgery For Osteoarthritis

Knee osteoarthritis (OA) is one of the most common orthopedic conditions. If you are experiencing OA, you understand the pain and discomfort involved and how it can negatively impact your quality of life and enjoyment of daily activities.

Historically, many patients over 40 with knee pain due to osteoarthritis (commonly referred to as arthritis) have been advised to try physical therapy, nonsteroidal anti-inflammatory medications (NSAIDs), hyaluronate or corticosteroid knee injections to reduce pain and inflammation. If these are not helpful, the next recommendation is often arthroscopic knee surgery to repair or remove any damaged cartilage or tissue that may be causing the pain. If the surgery doesn’t deliver the desired results, then total knee joint replacement is usually recommended.

Numerous studies² evaluating the results of common orthopedic knee surgeries have shown that these procedures generally don’t work unless the patient is younger than 40 years of age. Even then, successful outcomes are not guaranteed. If this is new information to you, you are not alone. Many are not aware that surgery isn’t always the solution. Read on to learn more about procedures using Regenexx injectates available at Rehabilitation Medicine Center of New Jersey, NY as an alternative to knee replacement surgery for osteoarthritis.

131 West 35th Street
12th Floor
New York, NY 10001

Request an Appointment

Call to Schedule Schedule Online

Doctors

Dr. Kramberg is a physiatrist in Wayne, New Jersey and has been in practice for more than 20 years.

He is a member of many prestigious medical organizations, including the American Academy of Physical Medicine and Rehabilitation, American Congress of Rehabilitation, American Pain Society, and American Society of Pain Medicine.

View Full Profile

Areas treated: Elbow, Foot & Ankle, Hand & Wrist, Hip, Knee, Lumbar Spine, Shoulder

How Does The Regenexx Approach Work For Knee Osteoarthritis?

At Regenexx, we invented a new approach to orthopedic care we call Interventional Orthopedics. This minimally invasive alternative to knee surgery uses ultrasound-guided technology to precisely inject your own bone marrow concentrate, which contains stem cells, directly where it’s needed in the joint.

The cells in your bone marrow concentrate work at the site of your injury to promote your body’s natural healing abilities and avoid surgery.

At Rehabilitation Medicine Center of New Jersey, NY, physicians in the licensed Regenexx network examine joint movement and may use ultrasound to observe joint function in real time. This evaluation helps identify the source of pain and joint dysfunction.

Treatment plans are customized to each individual and may include one or more of the following:

Regenexx SD Injectate: A patented protocol using bone marrow concentrate that contains stem cells

Regenexx SCP Injectate: A proprietary formulation of platelet-rich plasma (PRP) that’s more concentrated than what a basic bedside centrifuge machine can produce

Regenexx PL Injectate: Platelet lysate, which is a highly specialized derivative of platelet-rich plasma (PRP)

See how the Regenexx approach helped Stephanie with her chronic pain from knee osteoarthritis.

Am I a candidate?

Note: As with all medical procedures, those using Regenexx lab processes may result in varying outcomes. Patient testimonials and reviews reflect individual experiences and should not be considered predictive of results for others.

 

Below are MRI images from two individuals who underwent procedures using Regenexx lab processes for knee osteoarthritis. Scroll the arrow to the right to view the MRI of the knee joint before treatment, the white/lighter area may indicate areas of joint degeneration. Scroll to the left to view the MRI of the knee joint following the procedure.

Patient 1 MRI: 51 years old

Patient 2 MRI: 46 years old

Patient 1: This individual experienced limited improvement following a microfracture procedure and was unable to resume many daily activities. A procedure using a percutaneous injection of autologous cells prepared through Regenexx lab processes was later performed. Following the procedure, the individual reported returning to routine functional activities

Patient 2: This individual underwent arthroscopic debridement, during which a 3 cm by 4 cm osteochondral defect on the medial femur was identified. Approximately 1.5 years after surgery, the individual received a percutaneous procedure involving autologous cells processed using Regenexx lab methods. Subsequent to the procedure, the individual reported resuming full functional activities.

Am I a candidate?

Request an Appointment

TO TOP